# QELBREE

NDC: 17772-133
Generic name: viloxazine hydrochloride
Labeler / Manufacturer: Supernus Pharmaceuticals, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20210402

FDA application: NDA211964

## Active ingredients

- VILOXAZINE HYDROCHLORIDE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"17772-133"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=17772-133
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aedf408d-0f84-418d-9416-7c39ddb0d29a